Market Cap 19.70B
Revenue (ttm) 2.89B
Net Income (ttm) 492.70M
EPS (ttm) N/A
PE Ratio 39.24
Forward PE 39.09
Profit Margin 17.03%
Debt to Equity Ratio 0.07
Volume 737,326
Avg Vol 697,394
Day's Range N/A - N/A
Shares Out 71.94M
Stochastic %K 16%
Beta 1.08
Analysts Strong Sell
Price Target $350.00

Company Profile

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applicati...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 610 594 2900
Address:
530 Herman O. West Drive, Exton, United States
PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:32 AM
$WST is currently trading at $266.66, below both the 30-day moving average (MA30) of $275.55 and the 50-day moving average (MA50) of $268.47, indicating bearish momentum. The RSI at 27.24 suggests that the stock is oversold, which could signal a potential reversal or bounce in the near term. However, the price is still within a range defined by a 60-day high of $322.34 and a low of $241.5, suggesting significant volatility. For a trade plan, consider entering a long position if the price breaks above $270, which would indicate a potential upward movement. Set a stop loss at $261 to manage risk. Target 1 could be set at $280, aligning with the MA30, and Target 2 at $290, taking into account a potential retracement towards the mid-range of the recent high-low. Monitor the ATR of 10.17 for volatility adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:39 AM
$WST is currently trading at $278.18, showing a neutral RSI of 50.6, indicating no strong momentum in either direction. The price is above the 30-day moving average (MA30) of $275.71 and significantly above the 50-day moving average (MA50) of $267.6, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $322.34 and low of $241.5 provide a range that indicates potential volatility. Given the current position, a bullish bias is suggested, as the price is maintaining above key moving averages. Suggested entry: $279.00, with a stop loss at $272.00 to manage risk. Target 1: $290.00, which is a reasonable short-term resistance level. Target 2: $300.00, aligning with a psychological level and near the midpoint of the 60-day high. This trade plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:15 AM
$WST is currently trading at $278.18, showing a neutral RSI of 50.6, indicating no strong momentum in either direction. The price is above the 30-day moving average (MA30) of $275.71 and significantly above the 50-day moving average (MA50) of $267.6, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $322.34 and low of $241.5 provide a range that indicates potential volatility. Given the current position, a bullish bias is suggested, as the price is maintaining above key moving averages. Suggested entry: $279.00, with a stop loss at $272.00 to manage risk. Target 1: $290.00, which is a reasonable short-term resistance level. Target 2: $300.00, aligning with a psychological level and near the midpoint of the 60-day high. This trade plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 9:03 PM
🚀 New Signal ✅ 🏛️ $WST 🗓️ Nov 10, 2025 💵 Entry: $275.48 🎯 Target (Opt.): $283.72 (+2.99%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
StockConsultant
StockConsultant Nov. 4 at 7:28 PM
$WST West Pharmaceutical stock, strong day, watch for a breakout above 289.15 at https://stockconsultant.com/?WST
0 · Reply
Buffetty
Buffetty Nov. 4 at 4:29 PM
$WST Taking some 🍀🍀🍀
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 1 at 12:37 AM
$WST Share Price: $282.09 Contract Selected: Jun 18, 2026 $270 Calls Buy Zone: $34.17 – $42.21 Target Zone: $61.50 – $75.17 Potential Upside: 70% ROI Time to Expiration: 229 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 1:15 PM
$WST RSI: 59.95, MACD: 7.2999 Vol: 12.49, MA20: 274.72, MA50: 262.24 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
smartkarma
smartkarma Oct. 29 at 6:03 PM
$WST | West Pharmaceutical Services: High-Value Product Components Expansion As A Significant Needle Mover In The Company's Future Performance! "West Pharmaceutical Services delivered solid third-quarter results for 2025, showing noteworthy improvements across key metrics. The company..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/west-pharmaceutical-services-high-value-product-components-expansion-as-a-significant-needle-mover-in-the-company-s-future-performance
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 27 at 2:50 PM
$WST Really good write-up that perfectly summarizes WST's present situation. So if you want to bring your WST knowledge up to date or just discover WST, this is required reading. https://beyondspx.com/quote/WST/analysis/west-pharmaceutical-services-unleashing-high-value-growth-through-innovation-and-strategic-focus-nyse-wst
0 · Reply
Latest News on WST
West to Participate in Upcoming Investor Conferences

Oct 24, 2025, 6:00 AM EDT - 21 days ago

West to Participate in Upcoming Investor Conferences


West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand

Oct 23, 2025, 12:16 PM EDT - 22 days ago

West Pharma Soars After Q3 Beat, Lifts Outlook On GLP-1 Demand


West Reports Third-Quarter 2025 Results

Oct 23, 2025, 6:00 AM EDT - 22 days ago

West Reports Third-Quarter 2025 Results


West to Host Third-Quarter 2025 Conference Call

Oct 9, 2025, 6:00 AM EDT - 5 weeks ago

West to Host Third-Quarter 2025 Conference Call


Best Dividend Aristocrats For September 2025

Aug 27, 2025, 2:09 PM EDT - 2 months ago

Best Dividend Aristocrats For September 2025

ABBV ABT ADM ADP AFL ALB AMCR


West Pharmaceutical: Q2 Earnings Suggest Recovery

Jul 30, 2025, 12:20 PM EDT - 3 months ago

West Pharmaceutical: Q2 Earnings Suggest Recovery


West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars

Jul 24, 2025, 10:38 AM EDT - 4 months ago

West Pharma Lifts Outlook On Surging GLP-1 Demand, Stock Soars


West Welcomes Robert McMahon as Incoming Chief Financial Officer

Jul 21, 2025, 6:00 AM EDT - 4 months ago

West Welcomes Robert McMahon as Incoming Chief Financial Officer


West to Host Second-Quarter 2025 Conference Call

Jul 8, 2025, 6:00 AM EDT - 4 months ago

West to Host Second-Quarter 2025 Conference Call


PrivateProfiteer
PrivateProfiteer Nov. 14 at 3:32 AM
$WST is currently trading at $266.66, below both the 30-day moving average (MA30) of $275.55 and the 50-day moving average (MA50) of $268.47, indicating bearish momentum. The RSI at 27.24 suggests that the stock is oversold, which could signal a potential reversal or bounce in the near term. However, the price is still within a range defined by a 60-day high of $322.34 and a low of $241.5, suggesting significant volatility. For a trade plan, consider entering a long position if the price breaks above $270, which would indicate a potential upward movement. Set a stop loss at $261 to manage risk. Target 1 could be set at $280, aligning with the MA30, and Target 2 at $290, taking into account a potential retracement towards the mid-range of the recent high-low. Monitor the ATR of 10.17 for volatility adjustments. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 13 at 1:39 AM
$WST is currently trading at $278.18, showing a neutral RSI of 50.6, indicating no strong momentum in either direction. The price is above the 30-day moving average (MA30) of $275.71 and significantly above the 50-day moving average (MA50) of $267.6, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $322.34 and low of $241.5 provide a range that indicates potential volatility. Given the current position, a bullish bias is suggested, as the price is maintaining above key moving averages. Suggested entry: $279.00, with a stop loss at $272.00 to manage risk. Target 1: $290.00, which is a reasonable short-term resistance level. Target 2: $300.00, aligning with a psychological level and near the midpoint of the 60-day high. This trade plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
PrivateProfiteer
PrivateProfiteer Nov. 12 at 1:15 AM
$WST is currently trading at $278.18, showing a neutral RSI of 50.6, indicating no strong momentum in either direction. The price is above the 30-day moving average (MA30) of $275.71 and significantly above the 50-day moving average (MA50) of $267.6, suggesting a bullish short-term trend. However, the absence of a 200-day moving average limits long-term trend analysis. The 60-day high of $322.34 and low of $241.5 provide a range that indicates potential volatility. Given the current position, a bullish bias is suggested, as the price is maintaining above key moving averages. Suggested entry: $279.00, with a stop loss at $272.00 to manage risk. Target 1: $290.00, which is a reasonable short-term resistance level. Target 2: $300.00, aligning with a psychological level and near the midpoint of the 60-day high. This trade plan leverages current metrics to capitalize on potential upward movement while managing risk effectively. https://privateprofiteers.com
0 · Reply
SPYmyQQQ
SPYmyQQQ Nov. 10 at 9:03 PM
🚀 New Signal ✅ 🏛️ $WST 🗓️ Nov 10, 2025 💵 Entry: $275.48 🎯 Target (Opt.): $283.72 (+2.99%) 👉 FREE TRIAL! spymyqqq/join/
0 · Reply
StockConsultant
StockConsultant Nov. 4 at 7:28 PM
$WST West Pharmaceutical stock, strong day, watch for a breakout above 289.15 at https://stockconsultant.com/?WST
0 · Reply
Buffetty
Buffetty Nov. 4 at 4:29 PM
$WST Taking some 🍀🍀🍀
0 · Reply
SuperGreenToday
SuperGreenToday Nov. 1 at 12:37 AM
$WST Share Price: $282.09 Contract Selected: Jun 18, 2026 $270 Calls Buy Zone: $34.17 – $42.21 Target Zone: $61.50 – $75.17 Potential Upside: 70% ROI Time to Expiration: 229 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Oct. 31 at 1:15 PM
$WST RSI: 59.95, MACD: 7.2999 Vol: 12.49, MA20: 274.72, MA50: 262.24 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
smartkarma
smartkarma Oct. 29 at 6:03 PM
$WST | West Pharmaceutical Services: High-Value Product Components Expansion As A Significant Needle Mover In The Company's Future Performance! "West Pharmaceutical Services delivered solid third-quarter results for 2025, showing noteworthy improvements across key metrics. The company..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/west-pharmaceutical-services-high-value-product-components-expansion-as-a-significant-needle-mover-in-the-company-s-future-performance
0 · Reply
NVDAMillionaire
NVDAMillionaire Oct. 27 at 2:50 PM
$WST Really good write-up that perfectly summarizes WST's present situation. So if you want to bring your WST knowledge up to date or just discover WST, this is required reading. https://beyondspx.com/quote/WST/analysis/west-pharmaceutical-services-unleashing-high-value-growth-through-innovation-and-strategic-focus-nyse-wst
0 · Reply
nikitatrades
nikitatrades Oct. 25 at 6:59 PM
$WST - Beats, Raises, and Reassures The Headline: Strong Q3 beat followed by a guidance raise. The Numbers: EPS: $1.96 (Beat by 16%) Revenue: $804.6M (Beat) Key Takeaway: Raised full-year sales and profit guidance. A confident signal of operational stability and growth.
0 · Reply
IN0V8
IN0V8 Oct. 24 at 7:52 PM
$WST Buy Deutsche Bank raises PT to $345 from $305
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 3:06 PM
UBS has adjusted their stance on West Pharmaceutical Servs ( $WST ), setting the rating to Buy with a target price of 320 → 355.
0 · Reply
JarvisFlow
JarvisFlow Oct. 24 at 12:34 PM
Keybanc updates rating for West Pharmaceutical Servs ( $WST ) to Overweight, target set at 325 → 350.
0 · Reply
SuperGreenToday
SuperGreenToday Oct. 23 at 9:26 PM
0 · Reply
StocktwitsNews
StocktwitsNews Oct. 23 at 6:48 PM
WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components $WST $AVUS $XRMI https://stocktwits.com/news/equity/markets/wst-stock-soars-after-company-raises-full-year-guidance-on-strong-demand-for-glp-1-drug-components/cLG4YS9R3ro
0 · Reply
JarvisFlow
JarvisFlow Oct. 23 at 5:54 PM
Evercore ISI Group has updated their rating for West Pharmaceutical Servs ( $WST ) to Outperform with a price target of 390.
0 · Reply
notreload_ai
notreload_ai Oct. 23 at 5:12 PM
$WST raises its 2025 outlook after strong demand for self-injection devices drives revenue and profit above expectations. https://notreload.xyz/west-pharmaceuticals-raises-2025-outlook-as-self-injection-device-sales-surge/
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 4:59 PM
$WST surprise Q3 earnings beat — with a 17.4% EPS estimate beat and revenues up 7.7% year over year, driven by Proprietary Products and Contract-Manufactured Products. 📈 Yet, the stock has lagged the industry and S&P 500's gains this year. Opportunity assessment here 👉 https://www.zacks.com/stock/news/2775686/wst-stock-up-on-q3-earnings-beat-eps-view-raised-on-demand-fx-benefit?cid=sm-stocktwits-2-2775686-body-17343&ADID=SYND_STOCKTWITS_TWEET_2_2775686_BODY_17343
0 · Reply
ZacksResearch
ZacksResearch Oct. 23 at 3:59 PM
$WST just crushed Q3 — and raised its EPS outlook 🚀 Strong demand, FX tailwinds, and solid growth in Proprietary Products powered the beat, signaling momentum heading into year-end. Full breakdown of the bullish setup here 👉 https://www.zacks.com/stock/news/2775686/wst-stock-up-on-q3-earnings-beat-eps-view-raised-on-demand-fx-benefit?cid=sm-stocktwits-2-2775686-teaser-17341&ADID=SYND_STOCKTWITS_TWEET_2_2775686_TEASER_17341
0 · Reply
theoptionsplug
theoptionsplug Oct. 23 at 2:38 PM
Best performers in the S&P so far this morning $LVS $WST $DOW $MPWR
0 · Reply
DonCorleone77
DonCorleone77 Oct. 23 at 12:20 PM
$WST West Pharmaceutical reports Q3 adjusted EPS $1.96, consensus $1.69 -- Q3 revenue $804.6M, consensus $787.7M. -- Ups FY25 adjusted EPS view to $7.06-$7.11 from $6.65-$6.85, consensus $6.78. -- Raises FY25 revenue view to $3.06B-$3.07B from $3.04B-$3.06B, consensus $3.05B. -- Backs FY25 capital spending view $275M.
0 · Reply